Immediate Impact

1 by Nobel laureates 5 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

Tumour vasculature at single-cell resolution
2024 StandoutNature
Chemistry, structure and function of approved oligonucleotide therapeutics
2023 Standout
2 intermediate papers

Works of John R. Lowe being referenced

Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo
2007
Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors
2002

Author Peers

Author Last Decade Papers Cites
John R. Lowe 471 59 141 203 170 26 783
Allan Rosenthal 305 71 41 73 101 17 668
Catherine Blondin 261 20 162 73 33 25 832
Ohad Mazor 283 75 275 90 55 52 966
Rasappa Arumugham 292 33 97 46 63 31 705
Michael E. Hudson 550 179 120 121 59 15 912
Yuko Miyamoto 373 26 115 56 38 37 843
Micah Steffek 452 63 358 140 52 20 972
Karl Hecker 374 18 75 25 130 21 722
Maria D.F.S. Barbosa 439 44 328 103 137 24 935
Ying Yuan 273 24 73 182 57 27 766

All Works

Loading papers...

Rankless by CCL
2026